MANNATECH INC
Calidad de datos: 100%
MTEX
NASDAQ
Manufacturing
Chemicals
$5.22
▲
$0.03
(0.58%)
Cap. Mercado: 12.18 M
6 months return
—
Momentum
Neutral
5Y revenue growth
-6.07%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -6.07% annually over 5 years
Debt/Equity of 0.42 — conservative balance sheet
Negative free cash flow of -6.71 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.61%
Capital efficient — spends only 0.84% of revenue on capex
12 consecutive years of dividends — reliable payer
Price History
Crecimiento
Revenue Growth (5Y)
-6.07%
Below sector avg (1.82%)
Revenue (1Y)-10.68%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-31.37%
Above sector avg (-54.47%)
ROIC-3.03%
Net Margin-1.65%
Op. Margin-0.40%
Seguridad
Debt / Equity
0.42
Above sector avg (0.30)
Current Ratio1.13
Interest Coverage-6.01
Valoración
PE (TTM)
-5.34
Below sector avg (-1.49)
P/B Ratio1.75
EV/EBITDA7.69
Dividend YieldN/A
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1605 pares)
Comparado con empresas similares en Manufacturing
Comparación con Pares
vs mediana del sector Manufacturing (1605 pares) Comparado con empresas similares en Manufacturing| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -5.3 | -1.5 |
| P/B | 1.8 | 1.6 |
| ROE % | -31.4 | -54.5 |
| Net Margin % | -1.7 | -41.5 |
| Rev Growth 5Y % | -6.1 | 1.8 |
| D/E | 0.4 | 0.3 |
Precio Objetivo de Analistas
Consenso de analistas: objetivo medio vs precio actual y calificación.
No hay cobertura de analistas disponible
Estimaciones de Ganancias
Pronósticos de EPS e ingresos por período. Anual = años fiscales; trimestral = próximos trimestres.
No hay estimaciones futuras disponibles
No quarterly estimates available
Sorpresas de Ganancias
Últimos 2 trimestres
| Trimestre | EPS Est. | EPS Real | Sorpresa |
|---|---|---|---|
| Q12013 | — | $0.24 | — |
| Q32012 | — | $0.83 | — |
Historial de Dividendos
Pagos recientes por acción (más reciente primero).
| Ex-dividendo | Pago | Monto / acción |
|---|---|---|
| Jun 14, 2023 | — | $0.20 |
| Mar 15, 2023 | — | $0.20 |
| Dec 13, 2022 | — | $0.20 |
| Sep 13, 2022 | — | $0.20 |
| Jun 14, 2022 | — | $0.20 |
| Mar 15, 2022 | — | $0.20 |
| Dec 14, 2021 | — | $1.70 |
| Sep 14, 2021 | — | $0.20 |
| Jun 01, 2021 | — | $0.16 |
| Mar 15, 2021 | — | $0.16 |
| Dec 15, 2020 | — | $1.16 |
| Sep 14, 2020 | — | $0.16 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10.68% | Revenue Growth (3Y) | -7.32% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6.07% | Earnings Growth (5Y) | -20.59% |
| Profitability | |||
| Revenue (TTM) | 138.15 M | Net Income (TTM) | -2.28 M |
| ROE | -31.37% | ROA | -6.46% |
| Gross Margin | 76.48% | Operating Margin | -0.40% |
| Net Margin | -1.65% | Free Cash Flow (TTM) | -6.71 M |
| ROIC | -3.03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.42 | Current Ratio | 1.13 |
| Interest Coverage | -6.01 | Asset Turnover | 3.91 |
| Working Capital | 2.58 M | Tangible Book Value | 6.71 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | -36.61% | Dividend Growth (5Y) | -20.38% |
| Consecutive Div Years | 12 yrs | ||
| Valuation | |||
| P/E Ratio | -5.34 | Forward P/E | N/A |
| P/B Ratio | 1.75 | P/S Ratio | 0.09 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 7.69 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -55.14% | ||
| Market Cap | 12.18 M | Enterprise Value | 7.93 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.19 | Revenue / Share | 72.68 |
| FCF / Share | -3.53 | OCF / Share | -2.92 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | -16.91% |
| EPS CAGR (10Y) | -5.23% | ||
| Efficiency | |||
| CapEx / Revenue | 0.84% | FCF Conversion | 294.47% |
| SBC-Adj. FCF | -7.31 M | Growth Momentum | -4.61 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 117.87 M | 131.96 M | 137.21 M | 159.76 M | 151.41 M |
| Net Income | 2.49 M | -2.24 M | -4.49 M | 9.84 M | 6.26 M |
| EPS (Diluted) | 1.32 | -1.20 | -2.35 | 4.71 | 2.77 |
| Gross Profit | 91.46 M | 102.87 M | 104.15 M | 125.61 M | 115.90 M |
| Operating Income | 1.43 M | -964,000.0 | -405,000.0 | 9.05 M | 4.49 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 700,000.0 | 800,000.0 | 1.00 M | 1.20 M | 800,000.0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | 1.53 M | 1.63 M | 1.63 M | 1.72 M | 1.99 M |
| Interest Expense | -279,000.0 | 4,000.0 | 88,000.0 | 66,000.0 | 83,000.0 |
| Income Tax | 1.25 M | 1.11 M | 4.01 M | -950,000.0 | -536,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 36.06 M | 41.21 M | 49.13 M | 59.63 M | 65.34 M |
| Total Liabilities | 27.44 M | 30.72 M | 34.95 M | 35.21 M | 39.36 M |
| Shareholders' Equity | 8.61 M | 10.48 M | 14.18 M | 24.41 M | 25.97 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 11.40 M | 7.73 M | 13.78 M | 24.19 M | 22.21 M |
| Current Assets | 26.12 M | 27.66 M | 34.95 M | 42.84 M | 42.48 M |
| Current Liabilities | 20.90 M | 25.78 M | 29.84 M | 30.10 M | 31.99 M |
{"event":"ticker_viewed","properties":{"ticker":"MTEX","listing_kind":"stock","pathname":"/stocks/mtex","exchange":"NASDAQ","country":"US"}}